FDA Issues Final Rule on Safety Information During Clinical Trials

ROCKVILLE, Md., Sept. 28, 2010-The U.S. Food and Drug Administration today issued a final rule that clarifies what safety information must be reported during clinical trials of investigational drugs and biologics.  “This final rule will expedite FDA’s review of critical safety information and help the agency monitor the safety of investigational drugs and biologics,” said […]